a clinical trial to study the effects of two pain relief drugs,nalbuphine and butorphanol added to ropivacaine ,a numbing drug injected at the lower back into a space that carries nerves in patients undergoing lower extremity broken bone surgeries.
Not Applicable
- Conditions
- Health Condition 1: PCS- Health Condition 2: O- Medical and Surgical
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Age 18-60 years
Both gender
American Society of anaesthesiologists(ASA) physical status I and II
Patients undergoing lower limb orthopaedic surgeries under subarachnoid block.
BMI < 30
Exclusion Criteria
Patient refusal
ASA 3 and 4
Patients with local infection at the site of injection .
Patients with known or ascertained hypersensitivity to local anaesthetics.
Patient with coagulopathy, bleeding disorders and/or on treatment with anti-coagulants.
Spinal deformities.
-Pregnant women and lactating women
-Other contraindications for spinal anaesthesia
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method